American Journal of Medicine Studies
ISSN (Print): 2333-8881 ISSN (Online): 2333-889X Website: http://www.sciepub.com/journal/ajms Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medicine Studies. 2019, 7(1), 1-6
DOI: 10.12691/ajms-7-1-1
Open AccessArticle

Study on the Correlation between Serum 25-Hydroxyvitamin D3 Level and Obesity

Weijuan Song1, Ting Cui1, Qiuxia Ge2 and Ruixia Yang2,

1#These authors contributed equally to this work.

2Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, National Key Clinical Department of Laboratory Medicine, Nanjing, China

Pub. Date: July 03, 2019

Cite this paper:
Weijuan Song, Ting Cui, Qiuxia Ge and Ruixia Yang. Study on the Correlation between Serum 25-Hydroxyvitamin D3 Level and Obesity. American Journal of Medicine Studies. 2019; 7(1):1-6. doi: 10.12691/ajms-7-1-1

Abstract

Objective: To investigate the relationship between serum 25- hydroxyvitamin D3 [25-(OH)D3] and its related metabolic indexes in the obese. Methods: 239 obese patients, including 109 males and 130 females, were collected from the weight-loss clinic of Jiangsu People's Hospital from December 2016 to March 2018, and 221 physical examination samples, including 99 males and 122 females, were collected from physical examination Center of Jiangsu People's Hospital at the same time. The levels of 25-(OH)D3 were measured and their relationship with obesity, glycometabolism and lipid metabolism was analyzed. Results: BMI of males was significantly higher than that of females (p<0.05). There was no significant difference in the level of 25-(OH)D3 between men and women. With the increase of BMI, the level of 25-(OH)D3 showed a downward trend, with a significant difference (χ2=10.066, P < 0.05). The prevalence rate of simple obesity in 25-(OH)D3 more insufficient group was significantly lower than that in 25-(OH)D3 insufficient group (χ2=6.121, P < 0.05). Although the prevalence rate of hypertension, type 2 diabetes mellitus, hyperuricemia and hyperinsulinemia in the 25-(OH)D3 more insufficient group was higher than that in the 25-(OH)D3 insufficient group, there was no significant difference. Pearson correlation analysis showed that 25-(OH)D3 was negatively correlated with BMI (r= -0.197), C-peptide (C-P) (r= -0.134), and positively correlated with age (r= 0.168). Taking 25-(OH)D3 as dependent variable and other indexes as independent variables, multivariate linear regression analysis was performed. Age, BMI, total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) were independently correlated with 25-(OH)D3 ( beta values were 0.157, -0.164, 0.513 and-0.473 respectively). Conclusion: Obesity and related metabolic abnormalities are closely related to the decrease of 25-(OH)D3. The level of 25-(OH)D3 usually decreased in obese people, and the decrease of 25-(OH)D3 will lead to metabolic abnormalities such as obesity and hypertension.

Keywords:
25- hydroxyvitamin D3 obesity metabolic abnormalities

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Vanherwegen AS, Gysemans C, Mathieu C, Regulation of Immune Function by Vitamin D and Its Use in Diseases of Immunity, Endocrinol Metab Clin North Am, 46(4). 1061-1094. Dec. 2017.
 
[2]  Hossain MJ, Levinson A, George D, Canas J, Kumar S, and Balagopal PB, Vitamin D Status and Cardiovascular Risk in Obesity: Effect of Physical Activity in Nonvitamin D Supplemented Adolescents, Metab Syndr Relat Disord, 16(4). 197-203. May. 2018 .
 
[3]  Nappi L, Ottaviano M, Rescigno P, Fazli L, Gleave ME, Damiano V, De Placido S and Palmieri G, Long term deficiency of vitamin D in germ cell testicular cancer survivors, Oncotarget, 20.9(30). 21078-21085. Apr.2018.
 
[4]  Krysiak R, Szkróbka W, Okopień B, The Effect of Vitamin D on Thyroid Autoimmunity in Levothyroxine-Treated Women with Hashimoto's Thyroiditis and Normal Vitamin D Status, Exp Clin Endocrinol Diabetes, 125(4). 229-233. Apr.2017.
 
[5]  Horas K, Maier G, Jakob F, Maus U, Kurth A, Jakuscheit A, Rudert M, and Holzapfel BM, High Prevalence of Vitamin D Deficiency in Patients with Bone Tumors, Cancer Invest, 35(8). 562-568. Sep.2017.
 
[6]  Pilz S, Verheyen N, Grübler MR, Tomaschitz A and März W, Vitamin D and cardiovascular disease prevention, Nat Rev Cardiol, 13(7). 404-417. Jul. 2016.
 
[7]  Walker GE, Follenzi A, Bruscaggin V, Manfredi M, Bellone S, Marengo E, Maiuri L, Prodam F,and Bona G, Fetuin B links vitamin D deficiency and pediatric obesity: Direct negative regulation by vitamin D, J Steroid Biochem Mol Biol, 182.37-49. Sep. 2018.
 
[8]  Greene-Finestone LS, Garriguet D, Brooks S, Langlois K, and Whiting SJ, Overweight and obesity are associated with lower vitamin D status in Canadian children and adolescents, Paediatr Child Health, 22(8). 438-444. Nov.2017.
 
[9]  Cava RC, Javier AN, Vitamin D deficiency, N Engl J Med, 8.357(19). 1981-1982. Nov.2007.
 
[10]  Walsh JS, Bowles S, Evans AL, Vitamin D in obesity, Curr Opin Endocrinol Diabetes Obes, 24(6). 389-394. Dec.2017.
 
[11]  Viljakainen HT, Saarnio E, Hytinantti T, Miettinen M, Surcel H, Mäkitie O, Andersson S, Laitinen K, and Lamberg-Allardt C, Maternal vitamin D status determines bone variables in the newborn, J Clin Endocrinol Metab, 95(4). 1749-1757. Apr. 2010.
 
[12]  Pourshahidi LK, Vitamin D and obesity: current perspectives and future directions, Proc Nutr Soc, 74(2). 115-124. May. 2015.
 
[13]  Moschonis G, Androutsos O, Hulshof T, Dracopoulou M, Chrousos GP, and Manios Y, Vitamin D insufficiency is associated with insulin resistance independently of obesity in primary schoolchildren. The healthy growth study, Pediatr Diabetes, 19(5). 866-873. Aug. 2018.
 
[14]  Khundmiri SJ, Murray RD, Lederer E, PTH and Vitamin D, Compr Physiol, 6(2): 561-601. Mar. 2016.
 
[15]  Shu L, Huang K, Effect of vitamin D supplementation on blood pressure parameters in patients with vitamin D deficiency: a systematic review and meta-analysis, J Am Soc Hypertens, 12(7). 488-496. Jul. 2018.
 
[16]  Lips P, Eekhoff M, van Schoor N, Oosterwerff M, de Jongh R, Krul-Poel Y, and Simsek S, Vitamin D and type 2 diabetes, J Steroid Biochem Mol Biol, 173. 280-285. Oct .2017.
 
[17]  Sahebi R, Rezayi M, Emadzadeh M, Salehi M, Tayefi M, Parizadeh SM, Behboodi N, Rastgar-Moghadam A, Kharazmi Khorassani J, Khorassani SK, Mohammadi A, Ferns GA, and Ghayour Mobarhan M, The effects of vitamin D supplementation on indices of glycemic control in Iranian diabetics: A systematic review and meta-analysis, Complement Ther Clin Pract, 34. 294-304. Feb. 2019.
 
[18]  Gonzalez FJ, Moschetta A, Potential role of the vitamin D receptor in control of cholesterol levels, Gastroenterology, 146(4). 899-902. Apr. 2014.